SinoMab reports no change in issued shares for September

SinoMab BioScience Limited, a Hong Kong-incorporated company, filed its monthly return for September 2025, indicating no changes in its issued ordinary share capital. As of September 30, 2025, the total number of issued ordinary shares remained at 1,386,638,336, with zero treasury shares. The report confirmed that the company's authorized share capital and the concept of par value are not applicable due to its incorporation in Hong Kong.

The company's 2022 Share Option Scheme showed 69,009,462 share options outstanding at the close of the month. No new shares were issued during September pursuant to this scheme, and no treasury shares were transferred out. The total number of shares that may be issued or transferred out upon exercise of all share options to be granted under the scheme remains at 52,527,249.

SinoMab also confirmed compliance with all relevant listing rules, legal requirements, and authorisations concerning its securities movements, affirming that all money due from securities issuance has been received and all conditions for listing have been fulfilled.